Utah Medical Products Inc (NASDAQ:UTMD) Sellers Rose Their Shorts By 11.62%

June 27, 2018 - By Alice Reed

During Q1 2018 the big money sentiment decreased to 1.21. That’s change of 0.54, from 2017Q4’s 1.75. 8 investors sold all, 25 reduced holdings as Utah Medical Products, Inc. ratio dived. 22 increased stakes while 18 funds took stakes. Funds hold 2.48 million shares thus 3.44% more from 2017Q4’s 2.40 million shares.
Pnc Svcs Grp has 0% invested in Utah Medical Products, Inc. (NASDAQ:UTMD). 3,129 are owned by Rhumbline Advisers. National Bank Of Montreal Can, Ontario – Canada-based fund reported 94 shs. Blackrock reported 161,883 shs. California State Teachers Retirement reported 0% stake. Natl Bank Of America De has invested 0% of its capital in Utah Medical Products, Inc. (NASDAQ:UTMD). Cardinal Capital Mngmt owns 9,802 shs or 0.3% of their US capital. Invesco Limited invested in 0% or 2,296 shs. 7,700 are held by Strs Ohio. Morgan Dempsey Cap Mngmt Llc stated it has 0% of its capital in Utah Medical Products, Inc. (NASDAQ:UTMD). Ancora Advsr Limited Co reported 0.35% stake. California Public Employees Retirement System, California-based fund reported 19,965 shs. Ameritas Investment Prtn holds 296 shs or 0% of its capital. New York-based Bank Of New York Mellon has invested 0% in Utah Medical Products, Inc. (NASDAQ:UTMD). Stratos Wealth Ptnrs Ltd stated it has 465 shs or 0% of all its holdings.

Utah Medical Products, Inc. registered $4.97 million net activity with 0 buys and 17 insider sales since February 2, 2018. On Friday, February 2 HOYER ERNST G sold $4,459 worth of Utah Medical Products, Inc. (NASDAQ:UTMD). $90,700 worth of Utah Medical Products, Inc. (NASDAQ:UTMD) shs were sold by PAYNE BARBARA A.

Utah Medical Products Inc (NASDAQ:UTMD) had an increase of its shares shorted by 11.62%. It was issued in June by FINRA the 65,300 shares shorted on UTMD. The 58,500 previous shares are up with 11.62%. Previous UTMD’s position will need 5 days to recover. It has 12,900 average volume. Float short on Utah Medical Products Inc is 2.05%.

UTMD is reaching $113.4 during the last trading session, after decreased 1.00%.Utah Medical Products, Inc. has volume of 6,392 shares. Since June 27, 2017 UTMD has risen 57.69% and is uptrending. UTMD outperformed by 45.12% the S&P 500.

Utah Medical Products, Inc. develops, makes, and distributes medical devices for the healthcare industry worldwide.The firm is worth $423.04 million. It provides fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD, an infant respiratory hood; and DELTRAN PLUS, a blood pressure monitoring system.46.82 is the P/E ratio. The firm also offers umbilical vessel catheters; DIALY-NATE, a disposable peritoneal dialysis set; PALA-NATE, a silicone oral protection device; URI-CATH, a urinary drainage system; and MYELO-NATE, a lumbar sampling kit.

There’s a substantial Utah Medical Products, Inc. (NASDAQ:UTMD) news announced by Benzinga.com. It’s an item titled: “Benzinga’s Daily Biotech Pulse: Biohaven Sells Right To Drug, Obseva To Sell Shares” on June 19, 2018.

Utah Medical Products, Inc. (NASDAQ:UTMD) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.